Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Application of Tracer Kinetics in Drug Development: A Valuable but Underused Tool in Clinical Pharmacology

In this webinar, Pau Aceves, Associate Director of Consulting Services at Certara, presented case studies on how tracer kinetics were used to inform development of new drugs for lung, CNS, and liver diseases. By watching this webinar, you will learn how tracer kinetics can leveraged for PK, PD, and in silico modeling applications.

Speaker(s): Pau Aceves
Solution: Clinical Pharmacology Strategy, PK/PD Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info

Real Patients & Their Virtual Twins: A New Paradigm for Personalized Drug Safety Assessment

In this webinar, Sebastian Polak, Nikunj Patel, and Mark Holbrook introduced the Cardiac Safety Simulator (CSS) platform and explained how they developed a QSTS model for citalopram to serve as a “virtual twin” and help predict the likely occurrence of cardiotoxic events in real patients under different clinical conditions.

Speaker(s): Mark Holbrook, Nikunj Patel, Sebastian Polak
Solution: PBPK Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info

Validation Made Easier! Tips and Guidance from the Experts

In this webinar, Noreen Muscat from QACV Consulting discussed common pitfalls in validation and how to avoid them, and Allan Michaels, Sr. Project Manager of Phoenix Technology Services, shared how the latest Validation Suite for Phoenix WinNonlin expedites validation and provides robust reporting.

Speaker(s): Noreen Muscat, Allan Michaels
Solution: PK/PD Modeling & Simulation
More Info

Accomplish More with Phoenix—New Phoenix 8.1 Release in June 2018!

As the gold standard for PK/PD software, our upcoming Phoenix 8.1 release delivers new capabilities to automate processes, reduce errors, and save you time. Dr. Nathan Teuscher, VP of Pharmacometric Consulting, Venkateswari Muthukrishnan, Phoenix WinNonlin Product Manager, and Ana Henry, Executive Director of Training, shared our latest innovations in WinNonlin and NLME and conducted a live demo.

Speaker(s): Nathan Teuscher, Venkateswari Muthukrishnan, Ana Henry
Solution: PK/PD Modeling & Simulation
More Info

Optimizing the Timing of Maternal Influenza Vaccination

Infants face a gap in protection against influenza between birth and the time of vaccination. Thus, maternal immunization is the only way to prevent flu infection in pregnant women and newborns. Our current understanding of the optimal timing of vaccination is rudimentary. Watch this webinar with Dr. Michael Dodds to learn how modeling and simulation (M&S) offers an alternate approach to dedicated clinical studies to determine the best time to vaccine pregnant women against influenza.

Speaker(s): Michael Dodds
Solution: PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease, Pediatrics
More Info

Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients

In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how he used the Simcyp Simulator to predict olanzapine exposure in individual patients. By watching this webinar you will learn how PBPK modeling and simulation technology can be re-purposed to support model-informed precision dosing.

Speaker(s): Tom Polasek
Solution: PBPK Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info
Learn More LinkedIn Twitter Facebook Email